Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001171843-14-000111)

Filing Details

Accession Number:: 0001171843-14-000111
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-01-09 17:05:47
Reporting Period:: 2014-01-07

Filing Date:: 2014-01-09
Accepted Time:: 2014-01-09 17:05:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1365216	Sucampo Pharmaceuticals Inc.	SCMP	Pharmaceutical Preparations (2834)	133929237

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1370930	J Cary Claiborne	4520 East West Hwy, 3Rd Floor Bethesda MD 20814	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-01-07	2,400	$4.41	2,400	No	4	M	Direct
Common Stock	Acquisiton	2014-01-07	100	$4.07	2,500	No	4	M	Direct
Common Stock	Disposition	2014-01-07	2,500	$9.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2014-01-07	2,400	$0.00	2,400	$4.41
Common Stock	Employee Stock Option (right to buy)	Disposition	2014-01-07	100	$0.00	100	$4.07

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
105,560	2013-06-04	2021-05-02	No	4	M	Direct
105,460	2013-06-04	2021-10-17	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were realized pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2013.